- Published at
- by seekingalpha.com
neutral
neutral
EssilorLuxottica: U.S. Exposure Might Weigh On 2026 Targets
Despite a positive sales forecast for 2025, EssilorLuxottica's high valuation leaves no margin for error. Click here to find out why I rate ESLOY is a Hold.